Specifically, the LHRH analogue group demonstrated higher fasting glucose levels, basal insulin levels, and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) scores, indicating an elevated risk of diabetes. Here, INS is linked to diabetes mellitus.